A petition filed with the Securities and Exchange Commission is pressing the agency to mandate that publicly traded companies disclose to shareholders the material risks created by deep supply chain dependence on Communist China. The move comes amid growing concern that corporate America's reliance on a geopolitical rival openly committed to displacing the United States as the world's leading power has created a dangerous vulnerability.
The petition argues that investors deserve a clear accounting of just how exposed corporate America has become. It warns that an abrupt break in relations — whether from war, embargo, or economic coercion — could cripple the U.S. defense, healthcare, technology, and consumer economy overnight. The SEC has existing authority to demand clearer, more specific disclosures about geographic concentration risks, single-source dependencies, and scenario analyses for major supply disruptions, according to the filing.
China already controls decisive shares of vital materials and components. It mines roughly 70% of global rare earth elements and processes more than 90% of them. The United States relies on China for many critical minerals essential to F-35 jets, submarines, missiles, semiconductors, electric vehicles, and medical devices. Export controls imposed by Beijing in recent years are not abstract warnings; they are dress rehearsals for leverage, the petition states.
The pharmaceutical sector is equally exposed. China supplies 60% to 70% or more of key active pharmaceutical ingredients and precursor materials for antibiotics and other essential drugs. Much of the rest flows through India, which itself depends heavily on Chinese precursors. In a crisis, American hospitals, pharmacies, and military field hospitals would face immediate shortages — a national health emergency, not merely an economic inconvenience.
U.S. companies chased low prices and handed Beijing practical know-how, machinery, processes, and market share. The result is a rival that now dominates production across rare-earth magnets, solar wafers, steel, pharmaceuticals, and electric vehicles. Profit was never Beijing's sole objective; strategic dominance was, the petition argues.
Recent history proves the point. China embargoed rare earth exports to Japan in 2010 over a territorial dispute, forcing concessions without firing a shot. It has restricted gallium, germanium, and other materials in response to U.S. actions. Beijing is mapping foreign supply chains through licensing requirements precisely to identify pressure points for future coercion.
Current corporate disclosures on these risks are vague, inconsistent, and inadequate. If companies know the dangers, they are hesitant to alarm investors or invite regulatory scrutiny. That reluctance does not satisfy fiduciary duties or legal requirements for disclosure of material information, the petition contends. Investors cannot accurately price portfolio risk when required SEC filings gloss over the possibility of sudden loss of access to 70% to 90% of critical inputs. Policymakers similarly fly blind when assessing sanctions, tariffs, or defense strategies.
The petition calls on the SEC to require companies to quantify potential revenue, cost, and operational impacts from China-specific shocks. Vague boilerplate about "geopolitical tensions" is no longer acceptable, it states. Critics will claim such guidance burdens business or politicizes markets, but the opposite is true. Markets function best with accurate information. Concealing existential supply chain vulnerabilities distorts capital allocation and leaves shareholders exposed.
Free enterprise does not require pretending that doing business with a totalitarian rival bent on supremacy carries no unique downside, the petition argues. National security and economic resilience are not optional externalities; they are material facts. As war is costly and risky, China has implemented a strategy of "fighting without fighting" — weaponizing trade dependencies intentionally developed over decades.
Recent commentary from Treasury Secretary Scott Bessent underscores the linkage: Trade policy, industrial capacity, and national security are inseparable. Allowing foreign dependencies to degrade any one domain risks defining America's future on Beijing's terms, which is China's goal. The SEC should act promptly, the petition concludes. Investors deserve transparency. Companies owe their shareholders an honest assessment of risks, not happy-talk optimism. America's economy and security cannot afford willful blindness about the most consequential supply chain vulnerability of the time.